Related Experiment Video
Updated: Jun 18, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Coronavirus Disease 2019 and Takotsubo Syndrome
Ling Zhou1, Zijun Chen2, Riyue Jiang3
1Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China.
Insights
The COVID-19 pandemic is linked to Takotsubo syndrome (TTS), a cardiac condition. This review explores the causes, symptoms, and treatments for TTS during the COVID-19 era.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- The COVID-19 pandemic caused by SARS-CoV-2 has led to significant cardiovascular complications, including myocardial injury and cardiac dysfunction.
- Takotsubo syndrome (TTS), a form of cardiac dysfunction, has been increasingly observed in COVID-19 patients, particularly in intensive care settings.
- Over 119 cases of COVID-19 associated TTS have been reported since April 2020, highlighting a growing clinical concern.
Purpose of the Study:
- To review the current understanding of the pathogenesis and pathophysiology of TTS in the context of COVID-19.
- To provide an overview of clinical manifestations, diagnostic approaches, and treatment strategies for COVID-19 related TTS.
- To synthesize existing knowledge and guide clinical practice during the ongoing pandemic.
Main Methods:
- Literature review of published case reports and observational studies.
- Analysis of the role of Angiotensin-converting enzyme 2 (ACE2) as the viral receptor.
- Synthesis of information on clinical presentations, diagnostic criteria, and therapeutic interventions.
Main Results:
- COVID-19 patients exhibit cardiovascular complications, with TTS being a notable diagnosis.
- The interaction between SARS-CoV-2, ACE2 receptors in the heart, and the development of TTS is under investigation.
- Current understanding of COVID-19 related TTS is based on case reports and limited studies, with a lack of randomized trials.
Conclusions:
- TTS is a recognized complication of COVID-19, requiring careful monitoring and management.
- Further research, including randomized studies, is essential to elucidate the precise mechanisms and optimize treatment for COVID-19 related TTS.
- Clinical practice should adapt to incorporate current evidence for diagnosing and managing TTS in patients with COVID-19.
Abstract:
The novel coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global public health emergency. As the number of confirmed cases increases, cardiovascular complications, such as myocardial injury and cardiac dysfunction, are evidenced. Takotsubo syndrome (TTS), which is common in the intensive care unit, is diagnosed among COVID-19 patients. There have been 68 more cases reports with over 119 patients since a COVID-19 patient with TTS was first reported on April 14, 2020. Angiotensin-converting enzyme 2 (ACE2), which is widely expressed in the lungs and heart, is the virus receptor. Nevertheless, randomized studies on COVID-19 related TTS are lacking, and the pathogenesis and pathophysiology are still unclear. Therefore, this review provides an overview of the potential pathogenesis, pathophysiology, clinical manifestations, diagnosis, and treatment strategy for TTS in the COVID-19 era based on current practices.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pathophysiology of Heart Failure
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

